Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) (2010 - 2026)
Harvard Bioscience (HBIO) reported EPS (Weighted Average and Diluted) of -$0.77 for Q1 2026, down 899.43% on a QoQ basis from -$0.08 in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.77 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) changed N/A year-over-year to -$0.77 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.77 (changed N/A YoY) and the FY2025 annual result came in at -$1.29, down 352.66% from the prior year.
- EPS (Weighted Average and Diluted) declined to -$0.77 in Q1 2026 per HBIO's latest filing, from -$0.08 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.06 in Q2 2022 and bottomed at -$0.77 in Q1 2026.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.04 (2023), against an average of -$0.11.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) jumped 700.0%; it then tumbled 18625.93% in 2025.
- Tracing HBIO's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.05 in 2022, then grew by 28.27% to -$0.04 in 2023, then soared by 101.1% to $0.0 in 2024, then sank by 18625.93% to -$0.08 in 2025, then plunged by 899.43% to -$0.77 in 2026.
- Per Business Quant, the three latest HBIO EPS (Weighted Average and Diluted) figures stand at -$0.77 (Q1 2026), -$0.08 (Q4 2025), and $0.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -1.11 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 2.74 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 1.92 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.07 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 0.66 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.57 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -0.03 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 1.12 |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -0.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.77 |
| Dec 31, 2025 | -0.08 |
| Dec 31, 2024 | 0.00 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | -0.05 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | -0.17 |
| Jun 30, 2021 | -0.01 |
| Jun 30, 2020 | -0.04 |
| Mar 31, 2020 | -0.12 |
| Dec 31, 2019 | 0.02 |
| Sep 30, 2019 | -0.07 |
| Jun 30, 2019 | -0.01 |
| Mar 31, 2019 | -0.06 |
| Dec 31, 2018 | 0.09 |
| Sep 30, 2018 | -0.01 |
| Jun 30, 2018 | -0.04 |
| Mar 31, 2018 | -0.11 |
| Dec 31, 2017 | 0.03 |
| Sep 30, 2017 | -0.01 |
| Jun 30, 2017 | -0.01 |
| Mar 31, 2017 | -0.02 |
| Dec 31, 2016 | -0.04 |
| Sep 30, 2016 | -0.05 |
| Jun 30, 2016 | -0.02 |
| Mar 31, 2016 | -0.02 |
| Dec 31, 2015 | -0.51 |
| Sep 30, 2015 | -0.02 |
| Jun 30, 2015 | 0.01 |
| Mar 31, 2015 | -0.04 |
| Sep 30, 2014 | 0.02 |
| Jun 30, 2014 | 0.03 |
| Mar 31, 2014 | 0.02 |
| Dec 31, 2013 | -0.01 |
| Sep 30, 2013 | -0.03 |
| Jun 30, 2013 | -0.01 |
| Mar 31, 2013 | -0.03 |
| Dec 31, 2012 | 0.04 |
| Sep 30, 2012 | -0.01 |
| Jun 30, 2012 | 0.02 |
| Mar 31, 2012 | 0.02 |
| Dec 31, 2011 | 0.02 |
| Sep 30, 2011 | 0.00 |
| Jun 30, 2011 | 0.05 |
| Mar 31, 2011 | 0.06 |
| Dec 31, 2010 | 0.08 |
| Sep 30, 2010 | 0.44 |
| Jun 30, 2010 | 0.06 |